Brief: Glaukos Achieves Pipeline Milestone With Epioxa (Epi-on)
05/06/2023 13:18
June 5 (Reuters) - Glaukos Corp GKOS.N :
* GLAUKOS ACHIEVES PIPELINE MILESTONE WITH ENROLLMENT
COMPLETION
IN PHASE 3 CONFIRMATORY TRIAL FOR EPIOXA (EPI-ON)
Source text for Eikon: ID:nBw9ZS98ja
Further company coverage: GKOS.N
((Reuters.Briefs@thomsonreuters.com))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary